Literature DB >> 24015368

Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.

Mai-Phuong Hoang Vu1, Co Thach Nguyen, Le Khanh Hang Nguyen, Thi Kim Phuong Nguyen, Quynh Mai Le.   

Abstract

INTRODUCTION: Antiviral resistance has been reported in seasonal influenza A viruses and avian influenza A(H5N1) viruses in Viet Nam, raising concerns about the efficacy of treatment.
METHODS: We analysed specimens from two sources during the period 2009-2012: influenza-positive samples from influenza-like illness patients at sentinel clinics in northern Viet Nam and isolates from patients with confirmed A(H5N1) infections. Pyrosequencing was used to detect mutations: H275Y [for A(H1N1) and A(H5N1)], E119V [for A(H3N2)] and I117V [for A(H5N1)]. A neuraminidase inhibition assay was used to determine the Inhibitory Concentration 50 (IC₅₀) values for all influenza A and B isolates.
RESULTS: There were 341 influenza A positive samples identified; influenza A(H1N1)pdm09 was identified most frequently (n = 215). In 2009, oseltamivir resistance was observed in 100% (19 of 19) of seasonal A(H1N1) isolates and 1.4% (3/215) of A(H1N1)pdm09 isolates. This H275Y mutation was not found in influenza subtypes A(H5N1) or A(H3N2) isolates. DISCUSSION: In Viet Nam, seasonal and A(H5N1) influenza vaccines are not currently available; thus, effective treatment is required. The presence of oseltamivir-resistant viruses is therefore a concern. Active surveillance for oseltamivir resistance among influenza viruses circulating in Viet Nam should be continued.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24015368      PMCID: PMC3762967          DOI: 10.5365/WPSAR.2013.4.1.010

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN: 2094-7321


  16 in total

1.  A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.

Authors:  Quynh Mai Le; Heiman F L Wertheim; Nhu Duong Tran; H Rogier van Doorn; Tran Hien Nguyen; Peter Horby
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

2.  Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.

Authors:  A C Hurt; R T Lee; S K Leang; L Cui; Y M Deng; S P Phuah; N Caldwell; K Freeman; N Komadina; D Smith; D Speers; A Kelso; R T Lin; S Maurer-Stroh; I G Barr
Journal:  Euro Surveill       Date:  2011-06-09

3.  Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.

Authors:  Larisa V Gubareva; Robert G Webster; Frederick G Hayden
Journal:  Antiviral Res       Date:  2002-01       Impact factor: 5.970

Review 4.  Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.

Authors:  Aeron C Hurt; Hui-Ting Ho; Ian Barr
Journal:  Expert Rev Anti Infect Ther       Date:  2006-10       Impact factor: 5.091

5.  Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Authors:  Varough M Deyde; Tiffany G Sheu; A Angelica Trujillo; Margaret Okomo-Adhiambo; Rebecca Garten; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

6.  Avian flu: isolation of drug-resistant H5N1 virus.

Authors:  Q Mai Le; Maki Kiso; Kazuhiko Someya; Yuko T Sakai; T Hien Nguyen; Khan H L Nguyen; N Dinh Pham; Ha H Ngyen; Shinya Yamada; Yukiko Muramoto; Taisuke Horimoto; Ayato Takada; Hideo Goto; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2005-10-20       Impact factor: 49.962

7.  Molecular characterization of influenza A(H1N1)pdm09 virus circulating during the 2009 outbreak in Thua Thien Hue, Vietnam.

Authors:  Le Van An; Le Thi Bao Chi; Nguyen Hoang Bach; Huynh Thi Hai Duong; Massimo Deligios; Alberto Alberti; Piero Cappuccinelli
Journal:  J Infect Dev Ctries       Date:  2013-03-14       Impact factor: 0.968

8.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

9.  Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Authors:  Aaron D Storms; Larisa V Gubareva; Su Su; John T Wheeling; Margaret Okomo-Adhiambo; Chao-Yang Pan; Erik Reisdorf; Kirsten St George; Robert Myers; Jason T Wotton; Sara Robinson; Brandon Leader; Martha Thompson; Marjorie Shannon; Alexander Klimov; Alicia M Fry
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

10.  Reduced sensitivity of influenza A (H5N1) to oseltamivir.

Authors:  Jennifer L McKimm-Breschkin; Paul W Selleck; Tri Bhakti Usman; Michael A Johnson
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more
  9 in total

1.  Electrochemical assay to detect influenza viruses and measure drug susceptibility.

Authors:  Xiaohu Zhang; Abasaheb N Dhawane; Joyce Sweeney; Yun He; Mugdha Vasireddi; Suri S Iyer
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-30       Impact factor: 15.336

Review 2.  Deep sequencing: becoming a critical tool in clinical virology.

Authors:  Miguel E Quiñones-Mateu; Santiago Avila; Gustavo Reyes-Teran; Miguel A Martinez
Journal:  J Clin Virol       Date:  2014-06-24       Impact factor: 3.168

3.  Bifunctional thiosialosides inhibit influenza virus.

Authors:  Yang Yang; Yun He; Xingzhe Li; Hieu Dinh; Suri S Iyer
Journal:  Bioorg Med Chem Lett       Date:  2013-12-11       Impact factor: 2.823

4.  A case report of avian influenza H7N9 killing a young doctor in Shanghai, China.

Authors:  Hao Pan; Xi Zhang; Jiayu Hu; Jian Chen; Qichao Pan; Zheng Teng; Yaxu Zheng; Shenghua Mao; Hong Zhang; Chwan-Chuen King; Fan Wu
Journal:  BMC Infect Dis       Date:  2015-06-23       Impact factor: 3.090

5.  Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013.

Authors:  Hang K L Nguyen; Phuong T K Nguyen; Thach C Nguyen; Phuong V M Hoang; Thanh T Le; Cuong D Vuong; Anh P Nguyen; Loan T T Tran; Binh G Nguyen; Mai Q Lê
Journal:  Influenza Other Respir Viruses       Date:  2015-07       Impact factor: 4.380

6.  Prevalence of Influenza A(H1N1)pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012 - 2013.

Authors:  Nastaran Khodadad; Afagh Moattari; Mahmoud Shamsi Shahr Abadi; Mohammad Rahim Kadivar; Jamal Sarvari; Forough Tavakoli; Neda Pirbonyeh; Amir Emami
Journal:  Jundishapur J Microbiol       Date:  2015-08-29       Impact factor: 0.747

7.  Neuraminidase Gene Variations in Influenza A(H1N1)pdm09 Virus among Patients Admitted to Refferal Pulmonary Hospital, Tehran, Iran in 2009-2013.

Authors:  Payam Momeni; Shabnam Abedin Dargoosh; Ali Akbar Sedehzadeh; Ghazal Bagheri; Mojgan Mohammadi; Leila Poosashkan; Afsaneh Sigaroodi; Makan Sadr; Seyed Alireza Nadji
Journal:  Tanaffos       Date:  2017

8.  Glycan based detection and drug susceptibility of influenza virus.

Authors:  Hieu Dinh; Xiaohu Zhang; Joyce Sweeney; Yang Yang; Yun He; Abasaheb Dhawane; Suri S Iyer
Journal:  Anal Chem       Date:  2014-08-01       Impact factor: 6.986

9.  [Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu].

Authors:  J Poissy; O Terrier; B Lina; J Textoris; M Rosa-Calatrava
Journal:  Reanimation       Date:  2016-04-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.